Lateral Flow Immunoassay Based Rapid Test Market Grows With Increased POCT Under Homecare

Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2021: COVID 19 Growth And Change To 2030

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2021: COVID 19 Growth And Change To 2030

The Business Research Company’s Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2021: COVID-19 Growth And Change to 2030

LONDON, GREATER LONDON, UK, May 3, 2021 /EINPresswire.com/ — Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

The demand for point-of-care testing under home care settings is expected to drive the antibody lateral flow test market. Point-of-care testing (POCT) is essential for rapid on-site diagnosis and treatment. The most important features for current POCT diagnostic systems are a quick analysis time with a test-to-answer format. Lateral flow immunoassays are widely used as POCTs due to their speed and precision, simplicity and low cost, which is why the lateral flow assays market is in demand with these. For instance, the recent outbreak of coronavirus disease (COVID-19) has increased the significance of these devices to rapid screening and surveillance. Acro Biotech COVID-19 Rapid POC CE-IVD is a lateral flow immunoassay that quantifiably assesses the existence of patient-generated IgG and IgM antibodies to SARS-CoV-2, the causative agent of novel coronaviral disease COVID-19. These antibodies may be detected in whole blood, serum or plasma samples in the test cassette. OZO has developed three different variations of its products using the Latex Enhanced Lateral Flow Immunoassays method for testing COVID-19. Therefore, the need for point-of-care testing under home care settings is expected to drive the LFIA based rapid test market.

The lateral flow immunoassay (LFIA) based rapid test market consists of sales of devices and equipment used to run LFIA based rapid test and related services by companies that develop LFIA based rapid test equipment. These are testing devices used to assess the existence of a target, such as pathogens or biomarkers, in samples obtained from the human body or animals, or pollutants in water sources, food or animal feed.

Read More On The Global Lateral Flow Immunoassay Based Rapid Test Market Report:
https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-lfia-based-rapid-test-global-market-report-2020-30-covid-19-growth-and-change

The global lateral flow immunoassay (LFIA) based rapid test market is expected to grow from $5.77 billion in 2020 to $6.13 billion in 2021 at a compound annual growth rate (CAGR) of 6.4%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The lateral flow immunoassay market is expected to reach $9.13 billion in 2025 at a CAGR of 10%.

The global lateral flow immunoassay based rapid test market is segmented by technique into competitive assay, sandwich assay, multiplex detection assay, by end user into hospital & clinic, diagnostic laboratory, home care, others, and by application into infectious disease, pregnancy & fertility, toxicology, others.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2021: COVID-19 Growth And Change to 2030 is one of a series of new reports from The Business Research Company that provides Lateral Flow Immunoassay Based Rapid Test Market overview, forecast Lateral Flow Immunoassay Based Rapid Test Market size and growth for the whole market, Lateral Flow Immunoassay Based Rapid Test Market segments, and geographies, Lateral Flow Immunoassay Based Rapid Test Market trends, Lateral Flow Immunoassay Based Rapid Test Market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Lateral Flow Immunoassay Based Rapid Test Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3293&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

POC Hba1C Testing Market – By Product (Instruments, Consumables), By Technology (Ion-Exchange Hplc, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, Others), By End-User (Hospitals, Home Care, Others), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-market

Cell Based Assays Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Liquid Biopsy Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/liquid-biopsy-market-global-report

Interested to know more about The Business Research Company?

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *